LITTLE FALLS, N.J.,
Oct. 14, 2016 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) announced today
that its Board of Directors approved an increase in its semiannual
cash dividend from $0.06 to
$0.07 per outstanding share of the
Company's Common Stock. The dividend is payable on January 31, 2017 to shareholders of record at the
close of business on January 17,
2017.
"We are pleased to announce the increase in our dividend, which
will raise our annual payment from $0.12 to $0.14 per
share. This is the 7th consecutive year that we have
increased our dividend. The 17% increase demonstrates our
strong financial position and our confidence in future
performance," stated Charles M.
Diker, Chairman of the Board. "We're committed to creating
value for our shareholders and the dividend is an important
component."
Cantel Medical Corp. also announced today that effective
December 5, 2016, its trading symbol
for common stock listed on the New York Stock Exchange is changing
from "CMN" to "CMD".
About Cantel Medical
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, dialysate concentrates, hollow
fiber membrane filtration and separation products. Additionally, we
provide technical service for our products.
For further information, visit the Cantel website at
www.cantelmedical.com.
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-announces-17-increase-in-semiannual-dividend-and-new-stock-symbol-300345082.html
SOURCE Cantel Medical Corp.